leisure time -WSS

leisure time

author：knowledge 2025-09-28 04:42:28 - browse：52317

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Americans' trust in science, scientist continues decline: Report

hotspot

WSS

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Teach medical students about patients with intellectual disabilities

Burning questions about Delta and the next phase of the Covid pandemic

The response to Covid

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

focus

leisure time

knowledge

Peter Hotez and the public health issue of online harassment

Leukemia patients are helped by Syndax's new type of therapy

Medicare details structure of new drug price negotiation program

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Dobbs anniversary: the lost opportunity of abortion as health care

Pharma patents targeted by Biden in move to slash drug prices

Medical leaders decry Supreme Court decision on affirmative action

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

United colonoscopy coverage change 'may cost lives,' doctors say

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

leisure time

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

AI models in health care face new federal disclosure requirements

Inside the culture of fear in the White House science office of Eric Lander

FDA needs staff influx to meet gene therapy needs, Marks says

Americans' trust in science, scientist continues decline: Report

What Henrietta Lacks's story taught me about my role as a doctor

hotspot

leisure time

hotspot

leisure time